This inventor holds 1 USPTO granted patent. Top assignee: Farmitalia Carlo Erba S.r.l.. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Philippe De Taxis Du Poet: Innovator in Anti-Thrombin Polypeptides
Introduction
Philippe De Taxis Du Poet is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of biochemistry, particularly in the development of anti-thrombin polypeptides. His work has implications for medical treatments related to thrombosis and coagulation disorders.
Latest Patents
Philippe holds a patent for anti-thrombin polypeptides isolated from the leech Hirudinaria manillensis. The patent describes processes for their preparation, including methods for isolating these polypeptides from leech tissue or secretions, as well as synthesizing them through recombinant DNA techniques. The invention also provides DNA sequences, expression vectors, and host cell lines for the recombinant preparation of these polypeptides. The applications of these anti-thrombin polypeptides are particularly relevant in treating venous thrombosis, vascular shunt occlusion, and thrombin-induced disseminated intravascular coagulation. He has 1 patent to his name.
Career Highlights
Philippe is associated with Farmitalia Carlo Erba S.r.l., where he continues to advance his research and development efforts. His work in the pharmaceutical industry has positioned him as a key player in the innovation of therapeutic solutions.
Collaborations
Philippe has collaborated with notable colleagues such as Giampaolo Nitti and Emanuela Scacheri. Their combined expertise has contributed to the successful development of innovative solutions in the field of biochemistry.
Conclusion
Philippe De Taxis Du Poet is a distinguished inventor whose work on anti-thrombin polypeptides has the potential to significantly impact medical treatments for coagulation disorders. His contributions to the field exemplify the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile